Radiotherapy
A majority of malignant melanomas are resistant to radiotherapy but good results have been reported from the primary treatment of lentigo maligna melanoma and ocular melanoma (1).
The use of radiotherapy is therefore on a symptomatic basis.
- treatment of painful metastatic bone disease and brain secondaries
- sometimes used to palliate disease at many sites, particularly cutaneous metastatic deposits
- response rate is 40% at best
Reference:
Create an account to add page annotations
Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.